Medical/Pharmaceuticals News & Press Release Distribution

Medical/Pharmaceuticals

APAC
Global

Global Cord Blood Corporation to Report First Quarter Fiscal 2021 Financial Results

HONG KONG, Aug. 18, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release financial results fo...

2020-08-18 19:00 11486

Innovent and Lilly Announce Expansion of TYVYT® (Sintilimab Injection) Licensing Agreement

SUZHOU, China and INDIANAPOLIS, Aug. 18, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major disea...

2020-08-18 18:30 6418

Koichiro Matsumoto Appointed President/CEO of Bushu Pharmaceuticals Ltd.

KAWAGOE, Japan, Aug. 18, 2020 /PRNewswire/ -- In response to requests for a professional contract development and manufacturing organization (CDMO) partner inAsia that can better meet the needs and challenges of the global market, Bushu Pharmaceuticals Ltd. (hereinafter "Bushu Pharma") appointed ...

2020-08-18 14:00 1752

China Biologic Reports Financial Results for the Second Quarter of 2020

BEIJING, Aug. 17, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced its unaudited financial results for the second quarter of 2020. Second Quart...

2020-08-18 04:30 9901

WuXi Biologics Records Excellent Interim Results

Revenue Up 21.0% Y-o-Y to RMB1,944.1 Million Net Profit Up 62.6% to RMB730.7 Million Profit Attributable to Owners of the Company Up 63.6% Y-o-Y to RMB736.1 Million Adjusted Net Profit Up 40.7% Y-o-Y to RMB734.0 Million Diluted EPS Up 55.9% Y-o-Y to RMB0.53 Adjusted Diluted EPS Up 38.5% Y-o-Y to RMB...

2020-08-18 00:51 3237

Start of bridging pharmacokinetic and safety clinical trial of a novel solid pharmaceutical composition of AMPK activator O304

STOCKHOLM, Aug. 17, 2020 /PRNewswire/ -- In previous Phase I and Phase IIa clinical trials in healthy subjects and in type 2 diabetics, the small molecule AMPK activator compound O304 was administered as a suspension and with limited oral bioavailability. A novel formulation of O304 has now been ...

2020-08-17 22:13 2497

Sirtex Medical announces partnership with Magle Chemoswed

Collaboration grants Sirtex global use of innovative technology to develop novel imaging agent for interventional oncology WOBURN, Massachusetts, Aug. 17, 2020 /PRNewswire/ -- Sirtex Medical US Holdings, Inc. ("Sirtex"), a leading manufacturer of targeted liver cancer therapies, announced a coll...

2020-08-17 20:00 2355

I-Mab Announces First Patient Dosed in Phase 1b Study of Plonmarlimab in Rheumatoid Arthritis in China

SHANGHAI and GAITHERSBERG, Md., Aug. 17, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the first patient has been dosed with plonmarlimab ...

2020-08-17 20:00 3566

CARsgen Announces the Publication of a Novel CAR-T Technology that Improves the Efficacy of CAR-T cells Against Solid Tumors without Requiring Preconditioned Lymphodepletion

SHANGHAI, Aug. 17, 2020 /PRNewswire/ -- CARsgen Therapeutics, a leader in developing novel CAR-T cell therapies against solid tumors, today announced its publication of the 7×21 CAR-T technology in CLINICAL CANCER RESEARCH. The article is titled "Coexpression of IL-7 and CCL21 increases efficacy ...

2020-08-17 18:00 4022

First HBV Patient Dosed in Phase IIa Clinical Trial of ASC22, a Subcutaneously Administered PD-L1 Antibody

HANGZHOU, China and SHAOXING, China, Aug. 17, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today dosing of the first HBV patient in Phase IIa clinical trial of ASC22, which is a first-in-class, subcutaneously administered PD-L1 antibody. ASC22(Envafolimab) Phase IIa clin...

2020-08-17 08:30 3951

Sai Life Sciences opens new, state-of-the-art Research & Technology Centre in Hyderabad

HYDERABAD, India, Aug. 17, 2020 /PRNewswire/ -- Sai Life Sciences, one of India's fastest growing Contract Development & Manufacturing Organizations (CDMOs) , today announced the inauguration of its new Rese...

2020-08-17 08:00 3821

Sai Life Sciences opens new, state-of-the-art Research & Technology Centre in Hyderabad

China's First Trastuzumab Biosimilar Approved by NMPA

SHANGHAI, Aug. 17, 2020 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced onAugust 14 that the trastuzumab biosimilar HLX02, developed and manufactured by Henlius independently, has been approved by the National Medical Products Administration (NMPA). On 27th July, HLX02 (EU bran...

2020-08-17 08:00 4368

Ascentage Pharma Becomes a Constituent of Three Major Indexes Including Hang Seng Composite Index

SUZHOU, China, and ROCKVILLE, MD., Aug. 17, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the company has been s...

2020-08-17 07:30 3148

Memo Therapeutics AG and Northway Biotechpharma Collaborate on the Fast-Track Manufacturing of a SARS-CoV-2-Neutralizing Antibody for the Therapy of COVID-19

SCHLIEREN, Switzerland and VILNIUS, Lithuania, Aug. 15, 2020 /PRNewswire/ -- Swiss biotech companyMemo Therapeutics AG (MTx) and Northway Biotechpharma (Northway), a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announce a new partnership to manufacture MTx...

2020-08-15 08:36 4648

China Pharma Holdings, Inc. Reports Second Quarter 2020 Financial Results

HAIKOU CITY, China, Aug. 14, 2020 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced financial results for the qu...

2020-08-14 18:30 5966

Family Mask Supports UNGC Leaders' Summit 2020

HONG KONG, Aug. 14, 2020 /PRNewswire/ -- Family Mask is honoured to be an official supporting organization of United Nations Global Compact Leaders' Summit 2020, where more than 20,000 sustainability champions gathered over 26 hours of continuous virtual programming to address the private sector'...

2020-08-14 15:30 4219

Family Mask Supports UNGC Leaders' Summit 2020

Bushu Pharmaceuticals Announces Major Expansion Program

KAWAGOE, Japan, Aug. 14, 2020 /PRNewswire/ -- - Japan's Premier CDMO Will Invest $100m to Expand Capacity and Portfolio - Bushu Pharmaceuticals Ltd., one of Japan's largest contract manufacturers of pharmaceutical products, announced onAugust 14 a major capital program costing $100 million to ex...

2020-08-14 14:00 2562

Sinopharm Tech plans to purchase 337 tons Meltblown Fabric

HONG KONG, August 14, 2020 /PRNewswire/ -- Sinopharm Tech Holdings Limited ("Sinopharm Tech" and its subsidiaries, together, the "Group", stock code: 8156) is pleased to announce that, as of 13 August, 2020, the subsidiary of the Group has entered into product sales agreements with a branch of Pe...

2020-08-14 09:18 4892

Hankyung.com's introduces: "Seoul Made" PPE kits, targeting US Market

SEOUL, South Korea, Aug. 13, 2020 /PRNewswire/ -- "Seoul Made" PPE kits designed with Korean cultural themes and made by small businesses inSeoul, was delivered to New York on August 13th With many stakeholders of New Jersey, New York, Brooklyn, Chamber of Commerce, and other related agencies e...

2020-08-14 08:00 1944

Aquavit Pharmaceuticals, Inc. Secures Court Order on Compensatory Sanctions Against Counterfeiters for Contempt on Patent and Trademark Infringement Case

NEW YORK, Aug. 14, 2020 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc. ("Aquavit") secured Compensatory sanctions against counterfeiters inthe United States District Court for the Southern District of New York in a civil action against U-Bio Med, Inc., et al. The judgment orders all profits earne...

2020-08-14 02:32 4180

1 ... 541 542 543544545 546 547 ... 608